Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

Melanoma Open House on May 24 At Moores UC San Diego Cancer Center

 

May 07, 2007  |  

Most people living in Southern California are familiar with skin cancer, but melanoma, its most deadly form, is not as well understood.  Prevention and diagnosis of melanoma are not clear-cut and the incidence and death rates are rising. Today melanoma affects one person in 34.

If you or someone you know has questions or concerns about melanoma, please plan to attend a free Melanoma Open House sponsored by the UC San Diego Moores Cancer Center from 6:30 to 8:30 p.m. Thursday, May 24.  Melanoma experts from the Cancer Center will share the latest information on prevention, detection, and medical and surgical therapies, and will answer questions.

Guests will also have the opportunity to use the “DermaScan” skin assessment device to view sun damage to their skin, which is often invisible to the naked eye.

The event will be held in the Goldberg Auditorium at the Center, 3855 Health Sciences Dr., La Jolla. Refreshments provided. Free parking. To attend, please call 858-822-6189 with name and the number attending.

This event is made possible with support from Schering-Plough, Novartis and UC San Diego.

# # #

Media Contact: Nancy Stringer, 619-543-6163,nstringer@ucsd.edu




Media Contact

Share This Article


Related News

8/26/2016
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and l ...
8/24/2016
While even the best wines eventually peak and turn to vinegar, a new study by researchers at University of California San Diego School of Medicine suggests a paradoxical trend in the mental health of ...
8/19/2016
Researchers at the University of California San Diego School of Medicine have found that a form of magnetic resonance imaging (MRI) that non-invasively measures fat density in the liver corresponds wi ...
8/19/2016
Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Strep ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: